Accelerate Diagnostics, Inc. (0H8E.L)
USD 1.48
(-6.88%)
USD 1.48
(-6.88%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 31.36 Million USD | -51.76% |
| 2022 | 65.01 Million USD | -21.71% |
| 2021 | 83.04 Million USD | -18.1% |
| 2020 | 101.4 Million USD | -24.57% |
| 2019 | 134.42 Million USD | -27.44% |
| 2018 | 185.26 Million USD | 47.61% |
| 2017 | 125.51 Million USD | 51.49% |
| 2016 | 82.85 Million USD | -40.53% |
| 2015 | 139.32 Million USD | 99.6% |
| 2014 | 69.8 Million USD | 60.72% |
| 2013 | 43.43 Million USD | 226.15% |
| 2012 | 13.31 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 30.72 Million USD | -2.05% |
| 2024 Q2 | 22.86 Million USD | -25.57% |
| 2023 FY | 31.36 Million USD | -51.76% |
| 2023 Q4 | 31.36 Million USD | -20.24% |
| 2023 Q3 | 39.32 Million USD | -21.16% |
| 2023 Q1 | 51 Million USD | -21.55% |
| 2023 Q2 | 49.87 Million USD | -2.2% |
| 2022 Q4 | 65.01 Million USD | -14.28% |
| 2022 Q1 | 70.35 Million USD | -15.28% |
| 2022 Q2 | 58.72 Million USD | -16.53% |
| 2022 Q3 | 75.84 Million USD | 29.15% |
| 2022 FY | 65.01 Million USD | -21.71% |
| 2021 FY | 83.04 Million USD | -18.1% |
| 2021 Q1 | 92.66 Million USD | -0.81% |
| 2021 Q2 | 93.98 Million USD | 1.43% |
| 2021 Q3 | 81.16 Million USD | -13.65% |
| 2021 Q4 | 83.04 Million USD | 2.32% |
| 2020 Q2 | 114.81 Million USD | -4.32% |
| 2020 Q1 | 119.99 Million USD | -10.74% |
| 2020 Q3 | 104.21 Million USD | -9.23% |
| 2020 Q4 | 93.42 Million USD | -10.36% |
| 2020 FY | 101.4 Million USD | -24.57% |
| 2019 Q1 | 172.18 Million USD | -7.06% |
| 2019 Q4 | 134.42 Million USD | -8.73% |
| 2019 FY | 134.42 Million USD | -27.44% |
| 2019 Q3 | 147.27 Million USD | -7.16% |
| 2019 Q2 | 158.64 Million USD | -7.86% |
| 2018 FY | 185.26 Million USD | 47.61% |
| 2018 Q4 | 185.26 Million USD | -7.67% |
| 2018 Q3 | 200.65 Million USD | -8.06% |
| 2018 Q2 | 218.25 Million USD | 2.41% |
| 2018 Q1 | 213.11 Million USD | 69.8% |
| 2017 FY | 125.51 Million USD | 51.49% |
| 2017 Q3 | 136.1 Million USD | -8.2% |
| 2017 Q1 | 74.4 Million USD | -10.2% |
| 2017 Q4 | 125.51 Million USD | -7.78% |
| 2017 Q2 | 148.25 Million USD | 99.26% |
| 2016 Q1 | 125.64 Million USD | -9.82% |
| 2016 FY | 82.85 Million USD | -40.53% |
| 2016 Q4 | 82.85 Million USD | -14.26% |
| 2016 Q3 | 96.63 Million USD | -12.56% |
| 2016 Q2 | 110.51 Million USD | -12.04% |
| 2015 Q2 | 53.34 Million USD | -15.77% |
| 2015 Q1 | 63.33 Million USD | -9.26% |
| 2015 FY | 139.32 Million USD | 99.6% |
| 2015 Q4 | 139.32 Million USD | 211.3% |
| 2015 Q3 | 44.75 Million USD | -16.11% |
| 2014 Q1 | 41.41 Million USD | -4.64% |
| 2014 Q4 | 69.8 Million USD | -7.12% |
| 2014 FY | 69.8 Million USD | 60.72% |
| 2014 Q3 | 75.15 Million USD | -8.13% |
| 2014 Q2 | 81.8 Million USD | 97.51% |
| 2013 Q4 | 43.43 Million USD | -5.45% |
| 2013 Q2 | 29.33 Million USD | -6.08% |
| 2013 Q1 | 31.22 Million USD | 134.52% |
| 2013 FY | 43.43 Million USD | 226.15% |
| 2013 Q3 | 45.93 Million USD | 56.6% |
| 2012 FY | 13.31 Million USD | 0.0% |
| 2012 Q4 | 13.31 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| QuidelOrtho Corporation | 8.56 Billion USD | 99.634% |